Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 has been added and the previous v3.3.2 entry along with the HHS Vulnerability Disclosure text were removed. No study details or content were changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the site-wide government funding status notice; this change does not affect the study details, eligibility criteria, or results presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedPosted results and updated outcome measures are now on the page for NCT05817669, including primary and secondary outcomes and safety data, with the Results First Posted date of 2025-07-18.SummaryDifference0.4%

- Check93 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.SummaryDifference3%

- Check100 days agoChange DetectedAdded version update to v3.1.0 and removed several topic headings (MedlinePlus drug safety topics and an older v3.0.2), indicating a reorganization and upgrade rather than new substantive content.SummaryDifference0.5%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.